Diabetic Patients

Esperion Reports Cholesterol Cut Up To 43% In Diabetics On New DrugEsperion Therapeutics' proposed new cholesterol-busting drug cut the level of low-density lipoprotein, the so-called bad choleterol, up to 43 percent in a Phase 2 test of diabetic patients.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen